scispace - formally typeset
Patent

Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand

Reads0
Chats0
TLDR
In this article, a protein having an affinity for an immunoglobulin, including an amino acid sequence obtained by introducing, into the amino acid sequences derived from any of E, D, A, B and C domains of Protein A, at least one amino acid substitution at any one or more of amino acid residues corresponding to positions 31 to 37 of the A and B domains, which are conserved in all the domains.
Abstract
An object of the present invention is to create a novel engineered Protein A ligand having better antibody dissociation properties in the acidic condition compared with known engineered Protein A ligands. The present invention provides a protein having an affinity for an immunoglobulin, including an amino acid sequence obtained by introducing, into an amino acid sequence derived from any of E, D, A, B and C domains of Protein A, at least one amino acid substitution at any one or more of amino acid residues corresponding to positions 31 to 37 of the A, B and C domains (positions 29 to 35 of the E domain, positions 34 to 40 of the D domain), which are conserved in all the domains, the protein having a lower affinity for an Fab region of an immunoglobulin than a protein having the amino acid sequence before introduction of the substitution.

read more

Citations
More filters
Journal ArticleDOI

Mechanism of antibodies purification by protein A.

TL;DR: This review has focused on the study of both native and engineered Protein A to understand its mechanism in the purification of antibodies to find interesting and stimulating answers to all questions.
Patent

Mutated immunoglobulin-binding polypeptides

TL;DR: In this article, a polypeptide with improved alkaline stability was revealed, which polyptide comprises a mutant of a B or C domain of Staphylococcus Protein A (SpA), as specified by SEQ ID NO 1 or SEQID NO 2, or of Protein Z, wherein at least the glutamine residue at position 9 has been mutated to an amino acid other than asparagine.
Patent

Protein for affinity-separation matrix

TL;DR: In this article, an engineered protein having a sequence obtained by replacing all the lysine residues in Protein A, which is the most typical protein ligand, with other amino acids, and adding Lysine at a terminal is presented.
Patent

Affinity chromatography matrix

TL;DR: In this article, a method of separating one or more immunoglobulin containing proteins from a liquid is proposed. But the method is not suitable for the handling of large amounts of liquid.
Patent

Protein ligand for affinity isolation matrix

TL;DR: In this article, the problem of developing modified protein ligands that maximize binding capacity and binding efficiency to a target molecule when a protein ligand is immobilized in an affinity isolation matrix is addressed.
References
More filters
Journal ArticleDOI

A synthetic IgG-binding domain based on staphylococcal protein A

TL;DR: In this paper, a synthetic IgG-binding domain based on staphylococcal protein A was designed with the aid of sequence comparisons and computer graphic analysis to overcome the difficulties of introducing site-specific changes into the repetitive gene.
Journal ArticleDOI

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity

TL;DR: Staphylococcus aureus produces a virulence factor, protein A (SpA), that contains five homologous Ig-binding domains that rely on a sequence-restricted conformational binding with residue side chains, suggesting that this common bacterial pathogen has adopted distinct molecular recognition strategies for affecting large sets of B and T lymphocytes.
Journal ArticleDOI

Protein A chromatography for antibody purification

TL;DR: A minimized SPA derivative has been constructed and a domain originating from SPA has been improved to withstand the harsh environment employed in industrial purifications.
Journal ArticleDOI

Future of antibody purification.

TL;DR: A wide survey of technologies that are competing to be part of a platform, and an assessment of those that have the most promise are provided.
Journal ArticleDOI

Limits of cooperativity in a structurally modular protein: response of the Notch ankyrin domain to analogous alanine substitutions in each repeat.

TL;DR: Structural and calorimetric data indicate that, despite its modular structure, the Notch ankyrin domain unfolds as a cooperative unit consisting of the six C-terminal repeats, and that this cooperativity is maintained in the presence of severely destabilizing substitutions in the N-Terminal and central repeats.